(untitled) - Hamid, O; Hodi, S (2015)
. Preliminary clinical safety, tolerability, and activity of atezolizumab (anti-PD-L1) combined with vemurafenib in BRAF V600 metastatic melanoma, in Presented at Society for Melanoma research 2015 Congress October 2015 San Francisco CA.